Esta compañía no ha anunciado ningún dividendo en el próximo trimestre, ni ha pagado dividendos en el último año.
Sobre ObsEva SA
Brian O'Callaghan, MBA
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.